DK112449B - Fremgangsmåde til fremstilling af 2,3-dihydro-5-pyridyl-1H-1,4-benzodiazepiner eller syreadditionssalte deraf. - Google Patents

Fremgangsmåde til fremstilling af 2,3-dihydro-5-pyridyl-1H-1,4-benzodiazepiner eller syreadditionssalte deraf.

Info

Publication number
DK112449B
DK112449B DK195764AA DK195764A DK112449B DK 112449 B DK112449 B DK 112449B DK 195764A A DK195764A A DK 195764AA DK 195764 A DK195764 A DK 195764A DK 112449 B DK112449 B DK 112449B
Authority
DK
Denmark
Prior art keywords
benzodiazepines
pyridyl
dihydro
preparation
acid addition
Prior art date
Application number
DK195764AA
Other languages
Danish (da)
English (en)
Inventor
R Fryer
R Schmidt
L Sternbach
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK112449B publication Critical patent/DK112449B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK195764AA 1963-04-19 1964-04-20 Fremgangsmåde til fremstilling af 2,3-dihydro-5-pyridyl-1H-1,4-benzodiazepiner eller syreadditionssalte deraf. DK112449B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27430363A 1963-04-19 1963-04-19

Publications (1)

Publication Number Publication Date
DK112449B true DK112449B (da) 1968-12-16

Family

ID=23047643

Family Applications (1)

Application Number Title Priority Date Filing Date
DK195764AA DK112449B (da) 1963-04-19 1964-04-20 Fremgangsmåde til fremstilling af 2,3-dihydro-5-pyridyl-1H-1,4-benzodiazepiner eller syreadditionssalte deraf.

Country Status (9)

Country Link
BE (1) BE646617A (de)
BR (1) BR6458448D0 (de)
CH (1) CH455809A (de)
DK (1) DK112449B (de)
ES (1) ES298897A1 (de)
FR (2) FR3682M (de)
GB (1) GB1012260A (de)
NL (1) NL138937B (de)
SE (2) SE313572B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2005845A1 (de) * 1969-02-12 1970-09-03 Sumitomo Chemical Company, Ltd., Osaka (Japan) Verfahren zur Herstellung von Benzodiazepinen und ihren Salzen

Also Published As

Publication number Publication date
SE329857B (de) 1970-10-26
NL6404216A (de) 1964-10-20
GB1012260A (en) 1965-12-08
DE1445892B2 (de) 1975-05-28
BE646617A (de) 1964-10-16
FR1398185A (fr) 1965-05-07
NL138937B (nl) 1973-05-15
ES298897A1 (es) 1964-10-16
BR6458448D0 (pt) 1973-08-16
CH455809A (de) 1968-05-15
FR3682M (de) 1965-11-15
SE313572B (de) 1969-08-18
DE1445892A1 (de) 1969-02-06

Similar Documents

Publication Publication Date Title
DK108495C (da) Fremgangsmåde til fremstilling af substituerede 6,7-benzomorphaner eller syreadditionssalte deraf.
DK108972C (da) Fremgangsmåde til fremstilling af lipoylpyridoxamin eller syreadditionssalte deraf.
DK130070B (da) Analogifremgangsmåde til fremstilling af 3,4-dihydroxyphenylalkanolaminer eller syreadditionssalte deraf.
DK108169C (da) Fremgangsmåde til fremstilling af 3-hydroxy-5-aminomethyl-isoxasol eller syreadditionssalte deraf.
DK116000B (da) Fremgangsmåde til fremstilling af amino-halogen-benzylaminer eller syreadditionssalte heraf.
DK117000B (da) Fremgangsmåde til fremstilling af substituerede phenylamino-1,3-diazacyclopentener-(2) eller syreadditionssalte heraf.
DK120548B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller 4-oxider eller syreadditionssalte deraf.
DK112872B (da) Fremgangsmåde til fremstilling af [1,2-α]-imidazopyridiner eller syreadditionssalte deraf.
DK121123B (da) Fremgangsmåde til fremstilling af 1,2-dihydro-4-phenyl-quinazolin-3-oxider eller syradditionssalte deraf.
DK107942C (da) Fremgangsmåde til fremstilling af 1,5-disubstituerede 3-aza-1-pentanoler eller syreadditionssalte deraf.
DK127507B (da) Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK112449B (da) Fremgangsmåde til fremstilling af 2,3-dihydro-5-pyridyl-1H-1,4-benzodiazepiner eller syreadditionssalte deraf.
DK120600B (da) Fremgangsmåde til fremstilling af 5-aryl-1,4-benzodiazepin-2-oner eller syreadditionssalte deraf.
DK125552B (da) Fremgangsmåde til fremstilling af 1,2,3,4-tetrahydroisoquinolin-2-carboxamidiner eller syreadditionssalte deraf.
DK116288B (da) Fremgangsmåde til fremstilling af 2,3-dihydro-1,4-benzodiazepiner eller syreadditionssalte deraf.
DK118667B (da) Fremgangsmåde til fremstilling af 1,3,4,5-tetrahydro-5-phenyl-2H-1,4-benzodiazepin-2-oner eller syreadditionssalte deraf.
DK106381C (da) Fremgangsmåde til fremstilling af 2-dimethylamino-3,5,6-trimethylpyrazin eller syreadditionssalte heraf.
DK106911C (da) Fremgangsmåde til fremstilling af 2,3-dihydro-5-aryl-1H-1,4-benzodiazepinderivater eller syreadditionssalte deraf.
DK107030C (da) Fremgangsmåde til fremstilling af substituerede 1,4-benzodiazepiner eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK105649C (da) Fremgangsmåde til fremstilling af 2-dimethylaminopyrazin eller syreadditionssalte deraf.
DK106093C (da) Fremgangsmåde til fremstilling af 2-pyrrolidino-1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK106144C (da) Fremgangsmåde til fremstilling af aryl-N-(1,2,5,6-tetrahydro-1,3-dialkyl-4-pyridyl)-alkanoylamider eller syreadditionssalte deraf.
DK107169C (da) Fremgangsmåde til fremstilling af 10-monoalkylaminoalkyl-10,11-dihydro-11-oxo-5H-dibenzo(b,e)(1,4)diazepiner eller syreadditionssalte deraf.
DK105472C (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK108726C (da) Fremgangsmåde til fremstilling af 1,3-dihydro-5-pyridyl-7-trifluormethyl-2H-1,4-benzodiazepin-2-oner eller syreadditionssalte deraf.